RETRACTED: Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB Pathway

Min Song, Liukun Meng, Xiaoxi Liu, Yan Yang

Open source

DOI
10.1021/acsomega.0c05826
Published
2021-02-09
Container
ACS Omega
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.0c05826,
  title = {RETRACTED: Feprazone Prevents Free Fatty Acid (FFA)-Induced
Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB
Pathway},
  author = {Min Song and Liukun Meng and Xiaoxi Liu and Yan Yang},
  year = {2021},
  journal = {ACS Omega},
  doi = {10.1021/acsomega.0c05826},
  url = {https://doi.org/10.1021/acsomega.0c05826}
}

RIS

TY  - JOUR
TI  - RETRACTED: Feprazone Prevents Free Fatty Acid (FFA)-Induced
Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB
Pathway
AU  - Min Song
AU  - Liukun Meng
AU  - Xiaoxi Liu
AU  - Yan Yang
PY  - 2021
JO  - ACS Omega
DO  - 10.1021/acsomega.0c05826
UR  - https://doi.org/10.1021/acsomega.0c05826
ER  - 

APA

Song, M., Meng, L., Liu, X., & Yang, Y. (2021). RETRACTED: Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB Pathway. ACS Omega. https://doi.org/10.1021/acsomega.0c05826

Source records